These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6350479)

  • 41. Severe oral lichen planus: treatment with an aromatic retinoid (etretinate).
    Hersle K; Mobacken H; Sloberg K; Thilander H
    Br J Dermatol; 1982 Jan; 106(1):77-80. PubMed ID: 7037037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A course of pirarubicin vesical irrigation at thirty mg effectively prevents post-TUR recurrence of superficial bladder cancer].
    Kawamura S; Fujioka T; Kubo T; Yoshida I; Takata K
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):465-70. PubMed ID: 8678499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Problematic aspects of placebo-controlled double-blind studies with highly effective drugs such as etretinate].
    Schwanitz HJ
    Z Hautkr; 1987 May; 62(10):785-6, 791. PubMed ID: 3303711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fluid intake and the risk of tumor recurrence in patients with superficial bladder cancer.
    Donat SM; Bayuga S; Herr HW; Berwick M
    J Urol; 2003 Nov; 170(5):1777-80. PubMed ID: 14532774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Preliminary results of a randomized study between intravesical adriamycin and thio-tepa in the treatment of superficial tumors of bladder].
    Allona Moncada A; Santos García Vaquero I; Polo Villar G; Díaz González R; González Martín M; Zuloaga Gómez A; Martínez Torres JL; Rodríguez Alvarez J; Duarte Vázquez JJ; Megino López JF
    Arch Esp Urol; 1984; 37(2):113-22. PubMed ID: 6431914
    [No Abstract]   [Full Text] [Related]  

  • 46. [The immunotherapy of bladder tumors and the immunoprophylaxis of disease recurrence].
    Korovin AI; Savvin VT
    Urol Nefrol (Mosk); 1996; (1):19-21. PubMed ID: 8659034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of etretinate (Tigason) in clearing and prevention of relapse of palmoplantar pustulosis.
    Lassus A; Lauharanta J; Juvakoski T; Kanerva L
    Dermatologica; 1983; 166(4):215-9. PubMed ID: 6343148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Diacetyl-glucaro-(1 leads to 4) (6 leads to 3)-dilactone (SLA) for prevention of bladder tumor recurrence].
    Shiraishi T; Nihira H
    Hinyokika Kiyo; 1970 Oct; 16(10):586-92. PubMed ID: 5529995
    [No Abstract]   [Full Text] [Related]  

  • 49. Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial.
    Goebell PJ; Otto T; Suhr J; Rübben H
    J Urol; 2002 Jul; 168(1):72-5. PubMed ID: 12050495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of plaque psoriasis with an aromatic retinoid (etretinate)].
    Melis M
    Rev Med Chil; 1984 Jan; 112(1):20-5. PubMed ID: 6377426
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study.
    Denzinger S; Burger M; Walter B; Knuechel R; Roessler W; Wieland WF; Filbeck T
    Urology; 2007 Apr; 69(4):675-9. PubMed ID: 17445650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemoprevention of superficial bladder cancer.
    Kamat AM
    Expert Rev Anticancer Ther; 2003 Dec; 3(6):799-808. PubMed ID: 14686702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M; McGarry R; Kupelnick B
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prophylactic combination therapy after TUR of superficial bladder cancer].
    Ao T; Uchida T; Yokoyama E; Kawakami T; Adachi K; Mashimo S; Endo T; Koshiba K
    Hinyokika Kiyo; 1993 Nov; 39(11):987-91. PubMed ID: 7505523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The prevention of recurrences of surface bladder cancer by BCG vaccinal immunotherapy].
    Matveev BP; Kariakin OB; Safiullin KN; Figurin KM; Levi DT; Vatin OE
    Urol Nefrol (Mosk); 1993; (5):27-9. PubMed ID: 8310581
    [No Abstract]   [Full Text] [Related]  

  • 56. Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup.
    Solsona E; Iborra I; Ricós JV; Monrós JL; Casanova J; Dumont R
    J Urol; 1999 Apr; 161(4):1120-3. PubMed ID: 10081851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Tumors of the bladder in women. Epidemiologic and therapeutic aspects. Apropos of 40 cases].
    Rabii R; el Moussaoui A; Rais H; Joual A; Debbagh A; el Mrini M; Benjelloun S
    Ann Urol (Paris); 1998; 32(3):166-71. PubMed ID: 9657034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The prevention of the recurrence of stage pTa bladder tumors using intravesical instillation of BCG].
    Wetzel O; Glemain P; Bouchot O; Guillonneau B; Baron M; Buzelin JM; Auvigne J
    Prog Urol; 1993; 3(4):595-607. PubMed ID: 8401620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high-grade bladder cancer? A long-term follow-up of a randomized study.
    Denzinger S; Wieland WF; Otto W; Filbeck T; Knuechel R; Burger M
    BJU Int; 2008 Mar; 101(5):566-9. PubMed ID: 17986289
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Combination chemotherapy of mitomycin C and cytosine arabinoside in the intravesical treatment for superficial bladder tumors: report 2. Evaluation of prophylactic intravesical infusion therapy].
    Ikeuchi T; Onodera Y; Kai Y
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):858-63. PubMed ID: 6426397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.